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Heat shock 60 kDa protein 1 (HSP60) is a chaperone and stress response protein responsible for protein folding and delivery of
endogenous peptides to antigen-presenting cells and also a target of autoimmunity implicated in the pathogenesis of atherosclerosis.
By two-dimensional electrophoresis and mass spectrometry, we found that exposure of human promyelocytic HL-60 cells to a
nontoxic concentration (10𝜇M) of 4-hydroxy-2-nonenal (HNE) yielded a HSP60 modified with HNE. We also detected adducts
of HNE with putative uncharacterized protein CXorf49, the product of an open reading frame identified in various cell and tissue
proteomes.Moreover, exposure of humanmonocytic THP-1 cells differentiated with phorbol 12-myristate 13-acetate to 10𝜇MHNE,
and to light density lipoprotein modified with HNE (HNE-LDL) or by copper-catalyzed oxidation (oxLDL), but not to native
LDL, stimulated the formation of HNE adducts with HSP60, as detected by immunoprecipitation and western blot, well over basal
levels. The identification of HNE-HSP60 adducts outlines a framework of mutually reinforcing interactions between endothelial
cell stressors, like oxLDL and HSP60, whose possible outcomes, such as the amplification of endothelial dysfunction, the spreading
of lipoxidative damage to other proteins, such as CXorf49, the activation of antigen-presenting cells, and the breaking of tolerance
to HSP60 are discussed.
1. Introduction
The decomposition of lipid peroxides during oxidative stress
releases a number of reactive aldehydic intermediates (keto-
aldehydes, 2-alkenals, and 4-hydroxy-2-alkenals) [1, 2] that
may induce protein modifications. The most reactive com-
pound is 4-hydroxy-2-nonenal (HNE) [3, 4] that plays a
significant role in the pathogenesis of a wide spectrum of
human diseases ranging from chronic inflammatory and
autoimmune diseases to neurodegeneration and cancer [5, 6].
By a redox proteomics approach, several functional groups
of cell proteins of critical importance for cell metabolism
and survival appeared to be exposed more than others to the
adverse consequences of redox imbalance and hence HNE
under cell stressful conditions [7, 8]. To clarify the molecular
basis of HNE antiproliferative effects previously observed in
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the macrophage-derived, human leukemic HL-60 cell line
[9], we searched previously for HNE-modified proteins in
the proteome of these cells. After 15-minute exposure to a
nontoxic dose (10 𝜇M) of HNE, we detected HNE adducts
with 𝛼-enolase in close vicinity of the plasmamembrane
[10]. In the present study, under identical conditions but
for longer time exposure (2 hours), we extended our search
to protein targets of HNE in HL-60 cells and identified
HNE adducts with heat shock 60 kDa protein 1 (HSP60) and
putative uncharacterized protein CXorf49 (UniProt identi-
fier: A8MYA2 - CX049 HUMAN), the product of an open
reading frame on chromosome X [11] (HGNC [Human Gene
Nomenclature Committee] identifier: 30891) recently also
detected in proteomic analyses of various cell types and
tissues [12–14].
Human HSP60 is a member of a superfamily of highly
conserved HSPs that controls protein folding and stress
responses [15]. By associating with endogenous cell peptides
and binding to scavenger receptors, such as the lectin-like
oxidized LDL receptor-1 (LOX-1) at the surface of dendritic
cells (DCs) and macrophages, HSPs are able to convey
cell antigens into the presentation machinery of antigen-
presenting cells (APCs) [16]. Furthermore, HSP60 and other
HSPs can function as potent danger-associated molecular
patterns (DAMPs) [17, 18].
In addition to HSP60, LOX-1 also recognizes proathero-
genic oxidized LDL (oxLDL) that is strongly implicated in the
initiation and progression of human atherosclerosis [19, 20].
HNE-histidine adducts served as LOX-1 ligands in oxLDL
and HNE-modified proteins and strongly contributed [21]
to a number of cell dysfunctions determined by oxLDL
in endothelial cells (ECs) and macrophages [22–30]. Upon
binding to LOX-1 on DCs, oxLDL were also able to induce
DC maturation [31]. HSP60 itself is recognized as a promi-
nent target of autoimmune responses in atherosclerosis.
The role of HSP60 as an immunopathogenic self-antigen in
atherosclerosis is supported by several reports of HSP60-
specific autoreactive T cells in atherosclerotic patients [32–
35]. Therefore, we next set to investigate, by an immuno-
precipitation and western blotting strategy, whether HNE
in protein-bound form, namely, HNE bound to LDL, might
incite the production of endogenous HNE and the formation
of adducts of HNE with cell proteins, particularly HSP60, in
the human monocytic leukemic THP-1 cell line. In fact, after
differentiation induced with phorbol 12-myristate 13-acetate
(PMA), these cells have been indicated as a useful experi-
mentalmodel of the interactions of humanmacrophageswith
vascular cells within the context of atherogenesis [36]. Upon
exposure toHNE,HNE-LDL, and LDL oxidized with CuSO
4
,
but not to native LDL, HNE-HSP60 adducts were formed in
THP-1 cells at levels well higher than in basal conditions.
The interest of finding HNE-HSP60 adducts in HL-60
cells exposed to HNE is severalfold. The formation of HNE-
HSP60 adducts might represent the modification of self
which is required for the breaking of tolerance to HSP60.
HNE modification might confer upon HSP60 the properties
of an EC stressor and adjuvant, capable of cooperating in the
promotion of endothelial dysfunction and APC differentia-
tion, and of a modified self-antigen, both of which may favor
the transition from the inflammatory reaction to the products
of lipid peroxidation and their adducts with cell proteins to an
autoimmune adaptive response on the way to atherosclerosis.
2. Materials and Methods
2.1. Cells and Culture Conditions. HL-60 and THP-1 cells
were cultured at 37∘C in humidified atmosphere of 5% CO
2
in air, in RPMI 1640 medium supplemented with 0.002M
glutamine, antibiotics, and 10%heat-inactivated foetal bovine
serum (FBS) (BiochromAG Seromed). Cells were monitored
daily for growth rate and cell viability by the trypan blue
exclusion test (Sigma-Aldrich).
2.2. Isolation and Modification of LDL. LDL was prepared
from EDTA-plasma of a normolipemic, fasting (12–14 h),
male healthy donor, by two short runs of zonal ultracentrifu-
gation in KBr in the density range of 1.006–1.225 g/mL. This
procedure significantly shortens the isolation time (3.5 h),
thereby minimizing the spontaneous oxidation of LDL [37].
All isolation and successivemodification steps with LDLwere
performed under sterile conditions. Protection of LDL from
the action of proteases and phosphatases was ensured by
addition of 2 × 10−6M aprotinin and 1mM EDTA. After
isolation, LDL was transferred to PBS, 1mM EDTA by
solvent exchange on 10mL Sephadex G 25 PD-10 gel filtration
columns (GE Healthcare) and further sterilized by filtration
through sterile 0.22 𝜇m pore-size microfilters. Before usage,
whenever required, LDL was transferred to EDTA-free PBS
by the same technique. LDL concentration was assayed by
a copper-chelate method. Native LDL was kept in air-tight
vials with no unused residual space and was used as soon
as possible after isolation. HNE modification of LDL at the
concentration of 0.9mg/mL was performed by reaction with
1mMHNE in PBS at 37∘C for 20 h.Metal-catalyzed oxidation
was performed by incubation with 20𝜇M CuSO
4
in PBS at
37∘C for 20 h.
2.3. Cell Treatments. Before treatmentwithHNE,HL-60 cells
were washed and resuspended in serum-free medium. 4-
Hydroxy-2-nonenal (HNE) (Calbiochem) was added to the
cell suspension (2 × 105 cells/mL) at the final concentration of
10 𝜇M. After 2 h from the start of the treatment, cell viability
was controlled with the trypan blue dye exclusion test and
10 × 106 cells were harvested, washed twice in cold PBS, pH
7.4, and used for protein extraction.
Before exposing THP-1 cells to HNE, native or modified
LDL, their macrophagic differentiation was induced with
phorbol 12-myristate 13-acetate (PMA). Cells were passaged,
while in the exponential growth phase, at the density of
1 × 106 cells/mL, in 60 mm Petri dishes, were cultured in
RPMI-1640 with 10% FBS for 24 h and then incubated with
30 ng/mL PMA for 48 h. Before the addition of stimuli, cells
were maintained in serum-free medium for another 10 h.
2.4. Detection of Reactive Oxygen Species (ROS). The detec-
tion of reactive oxygen species (ROS) was performed flu-
orimetrically. Briefly, 2 h after the addition of 10 𝜇M HNE,
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5 × 106 HL-60 cells were harvested, centrifuged, resuspended
in 40 𝜇L of PBS, and lysed by sonication. To the cell lysate,
10 𝜇L of 5 𝜇M 2󸀠-7󸀠-dichlorofluorescein diacetate (DCFH-
DA) was added. The mixture was incubated at 37∘C for
20min. Under these conditions, DCFH-DA was hydrolysed
to nonfluorescent DCFH, which was rapidly oxidized to DCF
(2󸀠-7󸀠-dichlorofluorescein) in the presence of ROS. The fluo-
rescence generated by the oxidation of DCFH was measured
and used for the quantification of ROS. The reaction was
stopped on ice by adding 1mL of 0.1M phosphate buffer, pH
7.4, containing 0.1% Triton X-100.
2.5. Antibodies. The mouse anti-HNE-histidine monoclonal
antibody used in this study was prepared in-house by Dr.
Koji Uchida. Polyclonal anti-HSP60 antibodies used included
H-300 rabbit anti-HSP60 antibodies (sc-13966, Santa Cruz
Biotechnology), raised against amino acids 274–573 at the C
terminus of human HSP60, and N-20 goat anti-HSP60 anti-
bodies (sc-1052, Santa Cruz Biotechnology), raised against a
N-terminal peptide of HSP60 of human origin.
2.6. Confocal and Epifluorescence Microscopy. 5 × 104 HL-60
cells were smeared onto a noncharged slide, fixed for 15min
in 4% paraformaldehyde, washed twice, permeabilized with
1% Triton X-100 at rt for 30min, and washed with PBS, pH
7.4. Thereafter, the slides were incubated with 1% BSA in
PBS, pH 7.4, at rt for 30min, and then with the anti-HNE-
histidine primary antibody at 4∘C overnight. The slides were
washed, incubated at rt for 1 h with secondary fluorochrome-
conjugated antibodies, washed again, mounted on coverslips,
and examined with a Leica TCS SP2 confocal microscope,
equipped with a HCX Apo 0.8 water immersion objective.
For epifluorescence microscopic analysis (Axioskop, Carl
Zeiss), slides were also counterstained with 4󸀠,6-diamidino-
2-phenylindole (DAPI).
2.7. Electron Microscopy. HL-60 cells were fixed and samples
were infiltrated in 2 : 1 (v : v) ethanol : LRW (London Resin
White) for 1 h, 1 : 2 (v : v) ethanol : LRW for 2 h and 100%LRW
overnight at 4∘C; all other stepswere carried out at rt. Samples
were embedded in gelatin capsules [38] and processed for
ultramicrotomy [39]. Single-antibody immunogold localiza-
tion was performed as previously described [40].
2.8. Preparation of HL-60 and THP-1 Cell Protein Extracts.
Total cell protein extracts of HL-60 cells exposed to HNE
were prepared by suspending 10× 106 cells in lysis buffer, con-
taining 0.05MTris/HCl, pH 7.4, 0.15MNaCl, 0.005MEDTA,
1% Nonidet, 0.001M PMSF, 0.001M sodium orthovanadate,
and 0.05% aprotinin. Total cell protein extracts of THP-1 cells
differentiated with PMA and exposed to HNE or native or
modified LDL were prepared by scraping the cells off Petri
dishes and suspending them in lysis buffer, containing 0.02M
Tris/HCl, pH 7.4, 0.15MNaCl, 1% Triton X-100, 10% glycerol,
plus protease inhibitor, and phophatase inhibitor cocktails
(Roche). Debris was discarded by centrifugation at 13000 g
at 4∘C. Protein concentration was assayed by a dye-binding
technique (Bio-Rad Laboratories).
2.9. Two-Dimensional Polyacrylamide Gel Electrophoresis (2-
DE). Proteins in HL-60 cell lysates were separated by two-
dimensional gel electrophoresis (2-DE), using isoelectro-
focusing (IEF) in immobilized pH 3–10 gradients, fol-
lowed by SDS-PAGE in 8–18% total acrylamide gradient
gels. Separate cell lysates obtained under test and control
conditions were analyzed simultaneously, and two repli-
cate separations were performed with each cell lysate,
one destined for silver staining (see Supplemental Mate-
rials and Methods in Supplementary Material available
online at http://dx.doi.org/10.1155/2015/296146) and the other
for immunoblotting with the anti-HNE-histidine antibody.
Repeated separations were performed per each experimental
condition. Analytical separations were performed with cell
lysate aliquots containing 50–200𝜇g of total proteins each.
Detailed information can be found in SupplementalMaterials
and Methods.
2.10. Electrophoretic Transfer and Immunodetection of Cell
Proteins Separated in 2-DE Gels. Cell proteins separated
by 2-DE were transferred onto polyvinylidene difluoride
(PVDF) membranes (Immobilon P, Millipore) by semidry
electrophoretic transfer in 0.025M Tris base, 0.01M glycine,
at the constant current of 0.8mAmp/cm2 for 1.5 h, using
a Multiphor II apparatus equipped with Novablot graphite
electrode plates (GE Healthcare). At the end of the transfer,
nonspecific binding sites on PVDFmembranes were blocked
with 5% blotting-grade nonfat dry milk (NDM) (Bio-Rad
Laboratories) in PBS, pH 7.4, and 0.2% Tween 20, at 4∘C
overnight. Membranes were rinsed 3 times in PBS, pH 7.4,
0.2% Tween 20, and incubated with a murine monoclonal
anti-HNE-histidine primary antibody (prepared in-house by
Dr. Koji Uchida), at the dilution of 1 to 2000 in 5% NDM in
PBS, pH 7.4, and 0.2% Tween 20, at rt for 1 h. Membranes
were washed twice in PBS, pH 7.4, and 0.2% Tween 20
for 15min each time and incubated with HRP-conjugated,
secondary anti-murine IgG antibodies, at the dilution of
1 : 5000 in 2.5% NDM in PBS, pH 7.4, and 0.2% Tween 20,
at rt for 1 h. Optimal dilutions of antibodies, as judged from
the signal-to-noise ratio, were selected in test experiments
conducted with various dilutions of primary (from 1 : 800 to
1 : 6400) and secondary antibody (from 1 : 8000 to 1 : 64000).
The Tween 20 concentration was also optimized. Finally,
membranes were washed twice in PBS-Tween for 15min each
time, incubated in ECL Plus developer (GE Healthcare) at rt
for 5min and chemiluminescence detected with Hyperfilm
ECL (GE Healthcare).
2.11. Identification of HNE-Modified Proteins by Mass Spec-
trometry. Standard patterns of 2-DE separation of the pro-
teome of HL-60 cells, under basal conditions and after
exposure to HNE, were derived from computer-assisted
overlay of the scans of multiple replicate, analytical 2-DE
gels, stained with silver nitrate or probed with anti-HNE-
histidine antibodies. Bidimensional maps of silver-stained
proteins were aligned with the corresponding chemilumines-
cent detection maps, in order to locate the proteins detected
by anti-HNE-histidine antibodies within the bidimensional
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separation pattern. Moreover, separation and immunode-
tection patterns obtained under test and basal conditions
were compared, in order to identify the proteins selectively
affected by the treatment with HNE. The protein spots
detected by anti-HNE-histidine antibodies thus identified
were manually excised from the gels with a clean scalpel,
placed in Eppendorf tubes and subjected to in-gel digestion
with trypsin, as detailed in Supplemental Materials and
Methods. Matrix-assisted laser desorption ionization-time of
flight/mass spectrometry (MALDI-TOF/MS) of the tryptic
digests of HNE-immunoreactive protein spots was carried
out with a PerSeptive Biosystems Voyager DE-PRO instru-
mentation (Framingham), equipped with a N
2
laser (337 nm,
3 ns pulse width). Extraction solutions, containing tryptic
digests from gel spots, were desalted and concentrated, using
Poros Oligo R3 microcolumns. The columns were washed
with 20𝜇L of 0.1% TFA. Retained peptides were eluted
directly onto theMALDI target, using 0.5 𝜇L of amatrix solu-
tion containing 10mg of alpha-cyano-4-hydroxycinnamic
acid (4-HCCA) in 1mL of 50% aqueous acetonitrile. Mass
spectra acquisitions were performed in positive reflectron
mode, by accumulating 200 laser pulses. The accelerating
voltage was 20 kV. External mass calibration was performed
with low-mass peptide standards (PerSeptive Biosystems).
Peptide assignments were accomplished using the GPMAW
software (http://www.gpmaw.com/). MS data were searched
against the NCBInr protein sequence data bases, using the
Mascot server (http://www.matrixscience.com/).
2.12. Western Blot Analysis of HSP60 Expression after HNE
Treatment of HL-60 Cells. In order to assess how treatment
with HNE affected HSP60 expression, HL-60 cells were
treated with 10 𝜇M HNE for 2 and 6 h, and 20𝜇g of pro-
tein extracts was separated by SDS-PAGE and electroblot-
ted onto nitrocellulose membranes (Bio-Rad Laboratories).
These were blocked at 4∘C overnight in Tris-buffered saline
containing 5%milk, 0.5% Tween 20, and incubated at rt with
the H-300 anti-HSP60 antibody (Santa Cruz Biotechnology)
and then with a horseradish peroxidase-conjugated sec-
ondary antibody (Bio-Rad Laboratories). Detection was car-
ried out by enhanced chemiluminescence (GE Healthcare).
Densitometric gel analyses were performed either with the
Multi-Analyst, version 1.1 software (Bio-Rad Laboratories),
or the NIH ImageJ, version 1.48 software. All results were
standardized using an anti-𝛽-actin antibody.
2.13. Immunoprecipitation and Western Blot Analysis of HNE
Adducts in HL-60 and THP-1 Cells Exposed to HNE or Native
or Modified LDL. Total protein lysates (100–1000 𝜇g) of HL-
60 cells were incubated with 2 𝜇g of H-300 primary anti-
HSP60 antibody, under shaking at 4∘C overnight. Thereafter,
35 𝜇L of protein A-Sepharose (Sigma Aldrich) was added at
4∘C for 2 h. After centrifugation, the pellets were washed
extensively in 0.02M Tris/HCl, pH 7.4, 0.15M NaCl, 1%
Nonidet, 0.005M EDTA, 0.001M sodium orthovanadate,
0.001M PMSF, and 0.05% aprotinin, mixed with 35𝜇L of
0.2M Tris/HCl buffer, pH 6.8, 2% SDS, 30% glycerol, and
16% 2-mercaptoethanol, and heated in boiling water bath for
2min. Supernatants were subjected to SDS-PAGE and west-
ern blotting with the anti-HNE-histidine antibody, under the
conditions already described for the immunodetection of cell
proteins separated in 2-DE gels.
Total protein lysates (1000–1500𝜇g) of THP-1 cells dif-
ferentiated with PMA were subjected to preclearing with
25 𝜇L of a 1 : 1 mix of protein A-Sepharose 4B, Fast Flow
(Sigma-P9424) and Protein G Sepharose 4B, Fast Flow
(Sigma-P3296) at 4∘C overnight, under rotary shaking. After
centrifugation, the supernatants were incubated with 1 𝜇g per
sample of the N-20 primary goat anti-HSP60 antibody at 4∘C
overnight, followed by 30 𝜇L of 1 : 1 Protein A : Protein G-
Sepharose mix at 4∘C for 2 h. After four washes in lysis buffer
(0.02M Tris/HCl, pH 7.4, 0.15M NaCl, 1% Triton X-100, 10%
glycerol, plus protease and phophatase inhibitors), immuno-
precipitated proteins were detached from protein A + G by
the addition of 12 𝜇L of concentrated Laemmli sample buffer
and incubation at 60∘C for 2 h. Immunoprecipitates were
separated by SDS-PAGE in 8% acrylammide minigels and
transferred to PVDF membranes in 0.025M Tris, 0.192M
glycine, pH 8.3, and 20% methanol. The membranes were
blocked with 10% NDM in PBS, pH 7.4, 0.1% Tween 20 (PBS-
Tween) at rt for 1 h, rinsed trice in PBS-Tween and incubated
with the anti-HNE-histidine primary antibody, at the dilution
of 1 : 2000 in 5% NDM in PBS-Tween, at 4∘C overnight. After
three washes of 5min each in PBS-Tween, the membranes
were incubated with HRP-conjugated, secondary anti-mouse
IgG antibodies, at the dilution of 1 : 5000 in 2.5% NDM in
PBS-Tween, at rt for 1 h. After three washes in PBS-Tween,
chemiluminescence was detected using the ECL Western
Blotting Reagent (GE Healthcare).
2.14. Statistical Analysis. The identifications of HNE-protein
adducts, obtained by comparing the protein sequences in
the NCBInr database with the sequences determined by
the MALDI-TOF-MS analyses of the products of the in-gel
digestions of the HNE-immunoreactive spots from the 2-
DE separations of the proteome of HL-60 cells treated with
HNE, were probed by submitting queries to the MASCOT
(Matrix Science) interface.The latter calculated the statistical
significance of identifications (expressed both in the form of
the minimal score corresponding to a statistical significance
𝑃 < 0.05 and in the form of the expectancy of random
identity), on the base of the following parameters: (1) the
number of peptides whose sequences matched the protein
sequence in the NCBInr database, divided by the number of
sequenced peptides; (2) the percent fraction of the sequence
of the identified protein covered by the sequenced peptides.
3. Results
3.1. Identification of Adducts of HNE within the Proteome of
HL-60 Cells. The present investigation followed a previous
study of ours [10], in which we showed that, in HL-60 cells
treated with nontoxic doses (10 𝜇M) of 4-hydroxy-2-nonenal
for 15min, HNE immunoreactivity was principally localized
at the level of the plasmamembrane and adducts of HNEwere
formed with the membrane-associated isoform of 𝛼-enolase,
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Figure 1: Confocal and epifluorescence microscopic analysis of HL-60 cells treated with 10 𝜇M HNE for 2 h. HL-60 cells (5 × 104) were
harvested after 2 h of treatmentwith 10𝜇MHNE, fixed, permeabilized, blocked, and incubated overnightwith the anti-HNE-histidine primary
antibody at 4∘C, as described in Section 2. Cells were thenwashed and exposed to the FITC-conjugated secondary antibody for 1 h at rt, washed
again, mounted on coverslips, and examined under a Leica TCS SP2 confocal microscope, equipped with a water immersion HCX Apo 0.8
objective (a). For epifluorescence microscope analysis (Axioskop, Carl Zeiss), slides were also counterstained with DAPI (b).
whereas in cells subjected to a longer-lasting treatment (2 h),
HNE immunoreactivity diffused through the cytoplasm and
some of it was detected also in the nuclei. In the present
study, we sought to identify other targets of HNE adduct
formation in HL-60 cells treated with 10 𝜇M HNE for 2 h.
In preliminary experiments using confocal, epifluorescence,
and electronmicroscopy, we confirmed that, after HNE being
added to HL-60 cells, HNE completely pervaded them in
120min. In treated cells, HNE immunoreactivity was uni-
formly diffused in the cytosol and the nuclei, while none was
detected with the anti-HNE-histidine monoclonal antibody
in control cells (Figures 1(a) and 1(b)). Electron microscopic
analysis of the subcellular distribution ofHNE, using a single-
antibody immunogold localization technique, confirmed the
cytosolic, mithocondrial, and nuclear localization of HNE
adducts (Figure 2). Treatment with 10 𝜇MHNE did not exert
6 Oxidative Medicine and Cellular Longevity
Scale bar = 0.5𝜇m
C
N
Scale bar = 0.5𝜇m
C M
Figure 2: Electron microscopic analysis of HL-60 cells treated with 10 𝜇M HNE for 2 h. HNE-treated HL-60 cells were exposed to the
anti-HNE-histidine antibody and subjected to electron microscopy and single-antibody immunogold localization as described in Section 2.
Black arrows mark immune complexes between HNE-modified proteins and anti-HNE-histidine antibodies in cytosol (C), nuclei (N), and
mitochondria (M).
either cytotoxic or prooxidant effects in HL-60 cells, as
demonstrated by the trypan blue dye exclusion test and by
DCFH-DA analysis (data not shown).
Protein extracts from control and treated cells were
prepared after treatment with HNE at 37∘C for 2 h for sep-
aration by 2-DE and analysis. Figure 3 shows silver-stained
2-DE polyacrylamide gels of total cell proteins of control
(Figure 3(a)) and HNE-treated HL-60 cells (Figure 3(c)) and
the respective immunoblots, prepared by electrophoretic
transfer of the respective gel replicas onto PVDF and probing
with a murine monoclonal anti-HNE-histidine antibody
(Figures 3(b) and 3(d)). The spots marked as numbers 1, 2, 5,
8, 12, 13, and 14 in the gels shown in Figures 3(a) and 3(c) were
not further analyzed, as they were present in both control and
test cells. Since HNE was not detectable in control cells, these
spots probably reflected someunspecific reactivity of the anti-
HNE-histidine antibody. On the contrary, the spots numbers
3, 4, 6, 7, 9, and 10, obtained from 200𝜇g of total protein
extracts of HL-60 cells treated with 10 𝜇M HNE at 37∘C for
2 h, were subjected to in-gel tryptic digestion, as described
under Section 2, and analyzed by MALDI-TOF/MS. The
peptide masses obtained from the MALDI-TOF/MS spectra
of the tryptic digests of spots number 3c and 4 were aligned
with the NCBInr data base, using the Mascot server. The
analysis of spot number 3c identified 17 peptides (Figure 4),
9 of which had experimentally determined masses matching
the theoretical masses of tryptic peptides (deriving from the
cleavage at the carboxyl side of Lys or Arg residues, unless the
next residue was Pro) of the human mitochondrial isoform
of heat shock 60 kDa protein 1 (chaperonin) (NCBI id:
gi|41399283|ref|NM 002156.4|; Uniprot identifier: P10809),
with a theoretical Mr of 61187 and a nominal pI of 5.70. The
MASCOT interface (Matrix Science) assigned to this identifi-
cation the score 103 (to be compared to a threshold score of 56
for a statistical significance with 𝑃 < 0.05) and an expectancy
of 1e-06 (Supplemental Figure S1). The analysis of spot 4
identified 15 peptides (Figure 5), 12 of which had experi-
mentally determinedmasses matching the theoretical masses
of tryptic peptides of the putative uncharacterized pro-
tein CXorf49 (NCBI id: gi|223468692|ref|NM 001145140.1|;
Uniprot identifier: A8MYA2), with a calculated Mr of 54611
and a nominal pI of 9.26. The MASCOT interface (Matrix
Science) assigned to this identification the score 161 (to
be compared to a threshold score of 67 for a statistical
significance with 𝑃 < 0.05) and an expectancy of 2.1e-11
(Supplemental Figure S2).
3.2. Previous Mass Spectrometric Identifications of Uncha-
racterized Protein CXorf49 in the PRIDE Proteomic Data-
base. A search for A8MYA2 in the EMBL-EBI PRIDE
Archive-proteomics data repository (http://www.ebi.ac.uk/
pride/archive/) disclosed the following proteomic analyses
and mapping projects of tissues or cell types, in which mass
spectrometry had previously revealed, among the peptides
identified, one or more peptides belonging to the uncharac-
terized protein CXorf49:
(1) the extracellular matrix of human aorta (PRIDE id:
PRD000269) and of human healthy versus aneurys-
matic abdominal aorta (PRIDE id: PRD000416-417)
[11];
(2) human plasma (PRIDE id: PXD000605);
(3) human cerebro-spinal fluid (PRIDE id: PXD000651-
657);
(4) the human oligodendrocyte-derived MO3.13 cell line
(PRIDE identifier PXD000263) [12];
(5) skinned rat cardiomyocyte myofilaments (PRIDE id:
PRD000165) [13];
(6) AKT2-interacting proteins in HEK293T cells (PRIDE
id: PXD000197);
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Figure 3: Separation by two-dimensional electrophoresis (2-DE) of the proteome of HL-60 cells under basal conditions ((a), (b)) and after
exposure to 10 𝜇MHNE at 37∘C for 2 h ((c), (d)). Total cell extracts, each containing from 50 to 200 𝜇g of total protein, were prepared from
1 × 106 HL-60 cell aliquots. The gels in (a) and (c) were silver-stained, and those in (b) and (d) were electrophoretically transferred to PVDF
membranes and probed with a murine anti-HNE-histidine monoclonal antibody, which was detected with a secondary anti-murine IgG
antibody, with chemiluminescent technique. Molecular weight standards (MW St) in kDa are marked at right of the gels in (a) and (c). The
signal detected by the use of the anti-HNE-histidine antibody in the immunoblots of (b) and (d) was used to identify, by visual alignment, the
corresponding spots in the gels shown in (a) and (c). The spots thus identified were assigned numbers. The spots identified in the proteomes
of both control and test cells are circled in purple, and those selectively identified in HNE-treated cells are circled in red.
(7) proteins interacting with the histone deacetylase
inhibitor suberoylanilide hydroxamic acid (PRIDE id:
PRD000443).
3.3. Expression of HSP60 in Control and HNE-Treated HL-
60 cells. In order to determine how the treatment with HNE
possibly affected the expression of HSP60 in HL-60 cells, we
performed western blots for HSP60 in control and HNE-
treatedHL-60 cells. HSP60 expression was notmodified after
the addition of 10 𝜇MHNE to test cells (Figure 6(a)).
3.4. Immunoprecipitation and Western Blot Analysis of HNE-
HSP60 Adducts in HL-60 and THP-1 Cells. In order to
confirm the formation of HNE adducts with HSP60, we
performed immunoprecipitations of the HL-60 cell lysates
obtained under basal conditions and after 2 h of exposure
to 10 𝜇M HNE. Crossed immunoprecipitation with anti-
HNE-histidine antibodies, followed by western blotting with
anti-HSP60 antibodies, and immunoprecipitation with anti-
HSP60 antibodies, followed by western blotting with anti-
HNE-histidine antibodies, confirmed the formation of the
HNE-HSP60 adducts (Figure 6(b)). Limited amounts of
HNE- and HSP60-cross-reactive material were detected by
this combined approach also in control cells. However,
the amounts of HNE-HSP60 adducts formed in stimulated
HL-60 cells were well above those evidenced under basal
conditions.
We next addressed the question, by a similar immuno-
precipitation and western blotting strategy, whether HNE in
protein-bound form, particularly HNE bound to apolipopro-
teins in oxidized LDL, a well-known inducer of macrophage
and endothelial dysfunction [21–30], might incite in target
cells the production of endogenous HNE and the formation
of adducts of HNE with cell proteins, particularly HSP60. To
this aim, we decided to test the human monocytic leukemic
THP-1 cell line. These cells have been reported to repre-
sent, after differentiation induced with phorbol 12-myristate
13-acetate (PMA), a useful model, for experimental purposes,
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of the interactions of human monocytes-macrophages with
vascular cells during vascular inflammation, particularly
atherogenesis [36]. LDL were isolated from a healthy, nor-
molipemic donor, under conditionsminimizing spontaneous
oxidation [37], to serve as a negative control. Moreover, we
modified LDL both by direct reaction with HNE (1mM
at 37∘C for 20 h) and by metal-catalyzed oxidation with
CuSO
4
(20𝜇M at 37∘C for 20 h). The latter was proven to
produce various oxidative modifications of LDL, including
the formation of HNE-histidine adducts [41]. Differentiated
THP-1 cells were tested also by exposure to 10 𝜇M HNE, as
a positive control. Before the addition of stimuli, the cells
were cultured for 10 h in RPMI 1640 medium without FBS,
in order to avoid the confounding effects of LDL from fetal
bovine serum. Stimulation was carried out for 4 h, since it
was reported that, in differentiated THP-1 cells exposed to
10 𝜇M HNE or to carbon nanoparticles, accumulation of
HNE adducts with cell components was seen starting from
4 h after the addition of stimuli on [42].The results are shown
in Figure 6(c). In THP-1 cells differentiated with PMA and
exposed to HNE, HNE-LDL, or oxLDL(Cu) (LDL oxidized
with CuSO
4
), but not to freshly isolated, native LDL, HNE
adducts with HSP60 were formed at levels distinctly higher
than under basal conditions.
4. Discussion
The experiments reported here led us to identify HSP60
and uncharacterized protein CXorf49 out of a small group
of components of the HL-60 cell proteome that were most
prone to form HNE adducts, upon exposure to nontoxic
(10 𝜇M) HNE concentrations. The human promyelocytic
leukemic line of HL-60 cells was selected in view of its
lack of endogenous peroxydizing ability, while the human
monocytic leukemic line of THP-1 cells was used, after differ-
entiation induced with PMA, as a model of the macrophagic
responses to cell stressors, such as oxLDL [36]. A number
of recent redox proteomic approaches, mainly in the field of
neurodegenerative diseases, have pinpointed the susceptibil-
ity of defined subsets of cell proteins, including enzymes of
metabolism, oxidative phosphorylation, and stress response
proteins, to modification by lipid peroxidation products
[7, 8]. The susceptibility of HSP60 evidenced in our study
may reflect its participation in the maintenance of proteins
exposed to oxidative damage, at cellular sites of increased
production of reactive oxygen species (ROS).
Human HSP60 is a member of a superfamily of highly
conserved chaperones, whose synthesis, exposure at the cell
surface, and extracellular release are upregulated in response
to stressing conditions. By associating with endogenous
cellular peptides, HSPs also allow their efficient presentation
to T cells. Dying cells release HSPs complexed with cell
antigens that are internalized via cell-surface receptors by
APCs, thereby facilitating antigen transfer and presentation
[43]. The binding and internalization of HSP60 are mediated
by the scavenger receptor lectin-like oxidized LDL receptor-1
(LOX-1), which is also the main receptor of proatherogenic
oxidized LDL (oxLDL) at the surface of ECs, monocyte-
derived macrophages, and vascular smooth muscle cells
(SMCs) [26].HSP60 and otherHSPs are also powerful danger
signals (DAMPs), inducing theTLR-4-dependentmaturation
and activation of APCs [18, 44]. Despite prevailing evidence
in favor of their proinflammatory actions [16], extracellu-
larly released HSPs display immunomodulatory suppressive
effects as well [45, 46]. Factors influencing this balance
include the level of HSP expression and the molecular form
in which HSPs are released from cells in connection with
the modality of cell death. High levels of HSPs passively
released from necrotic cells are immunostimulatory, while
HSPs secreted in exosome-bound form by apoptotic cells are
immunosuppressive [47, 48].
The data that we report stimulate a reflection on the
possible impact that the modification of HSP60 with HNE
might have in relation to its involment in the pathogenesis
of human disease, particularly atherosclerosis. Associations
were reported between high levels of HSP60 in plasma and
early carotid atherosclerosis [49, 50] and coronary heart
disease [51]. In patients with angiographycally normal coro-
nary arteries, the serum concentration of HSP60 correlated
with the extent of cardiac and microvascular dysfunction
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Figure 6: Immunoprecipitation and western blot analysis of HSP60 expression and of HNE-HSP60 adduct formation in HL-60 and THP-1
cells treated with HNE or with native or modified LDL. (a) left: lanes 1 and 3, control HL-60 cells incubated without additions for 2 and 6 h,
respectively; lanes 2 and 4, HL-60 cells exposed to 10 𝜇M HNE for 2 and 6 h, respectively. 𝛽-actin was used as a quantitative reference. (b)
left: immunoprecipitation of HL-60 cell protein extracts with anti-HNE-histidine antibodies (aHNE), followed by western blot with anti-
HSP60 antibodies (aHSP60) (above); immunoprecipitation of HL-60 cell protein extracts with anti-HSP60 antibodies (aHSP60), followed
by western blot with anti-HNE-histidine antibodies (aHNE) (below). (c) left: western blot with anti-HNE-histidine antibodies of the protein
extracts subjected to immunoprecipitation with N-20 anti-HSP60 antibodies, from THP-1 cells differentiated with PMA and exposed for 4 h
to 10 𝜇MHNE (HNE), 20𝜇g/mL of native LDL (LDL), 20 𝜇g/mL of LDLmodified with 1mMHNE (HNE-LDL) at 37∘C for 20 h, or 15𝜇g/mL
of oxLDL(Cu), that is, LDLmodified bymetal-catalyzed oxidationwith 20𝜇MCu(SO
4
) at 37∘C for 20 h.The positions of themolecular weight
standards (MWSt) of 50 and 75 kDa are marked at left. All panels, at right: densitometric scans, in the form of histograms, of the HSP60- and
HNE-immunoreactive bands of the respective immunoblots at the left side of the panels.
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[52]. Moreover, the presence of HSP60-reactive T cells in
atherosclerotic lesions, especially in the early phases of
disease, was repeatedly documented [30, 32–35, 53–56].
Atherosclerosis can be viewed as an immunoinflamma-
tory condition, in which a persisting inflammatory stimulus
sets the conditions for the breaking of tolerance to self-
antigens, thus initiating an adaptive autoimmune response,
which, in turn, perpetuates the inflammatory process. Early
lesions are first infiltrated by activated T cells [54, 57, 58],
which join the network of vascular-associated dendritic cells
(VADCs) [59] followed by monocytes/macrophages and vas-
cular SMCs, which predominate in advanced atheromatous
plaques [54, 57, 58]. The concept of atherosclerosis as an
autoimmune response against HSP60, proposed in 1992 [60],
has gained support in time [30, 61]. In this model, all
known risk factors set the stage for the immunoinflammatory
process, by acting as EC stressors sharing the ability to induce
the surface expression of adhesion molecules and HSP-60.
The former foster the influx of oxLDL and mononuclear cells
into the arterial intima, and the latter may function as a
DAMP, aiding in the triggering of autoreactive T-cells, and
a self-antigenic target.
Investigating the possible consequences of the modi-
fication of HSP60 with HNE seems warranted, given the
proatherogenic role played in atherosclerosis of humans [24,
25] and LOX-1-null mice [29] by oxLDL, which shares with
HSP60 the LOX-1 receptor. LOX-1 is upregulated in ECs
upon exposure to oxLDL [23]. Upon binding to LOX-1,
oxLDL induced the expression of adhesion molecules [62]
and monocyte chemoattractant protein-1 (MCP-1) [24] and
promoted the production of reactive oxygen species (ROS),
NF-𝜅B activation [25, 27, 63], and apoptosis [23], all of
which characterized the endothelial dysfunction, a crucial
early step in atherosclerosis [22, 26]. The formation of HNE
adducts with apolipoprotein B (Apo B) in LDL was strongly
implicated in the proatherogenic properties of oxLDL, as
it converted LDL into an atherogenic form taken up by
macrophages, leading to the formation of foam cells [64].
In competition binding experiments, HNE-histidine adducts
served as LOX-1 ligands in oxLDL,HNE-LDL, andHNE-BSA
[41]. The binding stimulated ROS formation and activated a
pathway of MAPK and NF-𝜅B activation [21].
There are several reasons of interest in finding HNE-
HSP60 adducts in HL-60 cells exposed to HNE and, to an
even greater extent, in THP-1 cells exposed toHNEandHNE-
modified LDL:
(1) The finding that HSP60 is also a target of the lipox-
idative damage that renders oxLDL proatherogenic and that
HNE-LDL themselves can act as a trigger not only for the
upregulation of HSP60 expression [30, 65], but also for its
modification with HNE, sets a scenario, in which different
HNE targets (LDL, HSP60), exerting diverse effects at a
common receptor site (LOX-1), might contribute synergysti-
cally to oxidative stress-induced inflammation. In addition,
due to its ability to convey endogenous antigens into the
presentation machinery of APCs, HNE-HSP60 might favour
the lipoxidative modification of other proteins, one example
of which may be uncharacterized protein CXorf49, thus
enforcing a “lipoxidative spread.”
(2) The modification of HSP60 with HNE might affect
its interactions with innate receptors at the surface of ECs,
macrophages, VADCs, and their consequences on the balance
between tolerizing and positive costimuli provided by APCs
to autoreactive T cells in conjunction with self-antigenic
determinants [66]. In this regard, it is worth noticing that the
binding of oxLDL to LOX-1 at the surface of DCs induced the
upregulation of scavenger receptors and the maturation and
differentiation of DCs, with the expression of costimulatory
molecules [31].
(3) Furthermore, the formation of HNE adducts might be
the modification of self that is still required for the breaking
of immunological tolerance to HSP60 and the triggering of
adaptive autoimmunity. Infections with Chlamidia pneumo-
niae have been indicated as a risk factor of atherosclerosis.
The susceptibility to vascular disease would be the price
paid by human beings for developing protective immunity
against microbial infections, due to the high degree of
sequence homology between bacterial HSP60’s (over 95%)
and between prokaryotic andmammalian HSP60 (over 50%)
[30, 61]. However, under physiological conditions, humans
seem to be tolerant to autologous HSP60, with negative cen-
tral selection [67, 68] and peripheral failsafemechanisms pre-
venting the onset of autoimmunity against HSP60 [69]. The
associations reported between the occurrence and severity
of cardiovascular disease and the titers and cross-reactivities
of antibodies against human and bacterial HSP60’s were
inconsistent (reviewed in [30]). On the other hand, epitopic
mimicry between bacterial and humanHSP60may not be the
sole way of triggering an autoimmune response.Modification
of human HSP60 with HNE as a result of lipid peroxidative
damage might be just another way.
It is worthy noting that, in a recent report [70], the
ability of LDL modified by oxidation or by human group
X-secreted phospholipase A2 to induce DC activation and
Th1 andTh17 cell differentiation was attenuated by lentiviral-
mediated shRNA knockdown of HSP60 and HSP90 in DC,
which indicates their involvement in the activation of T-cell
responses in atherosclerosis.
Ultimately, the modification of HSP60 with HNE might
both contribute to the oxidative stress-driven inflammation
of the arterial intima and act as a switchover to the immunity-
driven perpetuation of the inflammatory disease process.
Verification of these hypotheses will entail gaining proof for
the occurrence of the modification of HSP-60 with HNE
in vivo and studying its functional consequences on DCs
and human ECs. The results may confirm or rule out the
significance of HNE-modified HSP60 as a marker/predictor
of atherosclerosis.
5. Conclusions
In the human promyelocytic leukemic HL-60 cell line
exposed to a nontoxic concentration (10 𝜇M) of HNE, HSP60
alongside uncharacterized protein CXorf49 was among the
cell proteins most susceptible to the formation of HNE
adducts. In humanmonocytic leukemic THP-1 cells differen-
tiated with PMA the formation of HNE adducts with HSP60
was confirmed upon exposure to HNE, but also in response
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to LDLmodifiedwithHNE or by copper-catalyzed oxidation,
but not to native LDL.
In the light of the well-established pathogenic role of
HSP60 as a target of autoimmune adaptive responses in
atherosclerosis, the interest of this observation is severalfold.
(1) SinceHSP60 shares the scavenger receptor LOX-1with
oxidized LDL, a determinant of EC dysfunction and foam cell
formation in early stages of atheroma formation, and because
HNE-histidine adducts are a major determinant of oxLDL
binding to LOX-1, it is probable that HNE-HSP60 may act
synergistically with oxLDL and other EC stressors.
(2) As the fate of the presentation of HSP-associated
antigens is affected by the inflammatory milieu, the mode
of cell death, and the molecular form and mechanism of
extracellular release of HSPs, HNE modification might affect
the proven ability of HSP60 to induce DC maturation and
differentiation into a T-effector-, rather than a T-regulatory-
promoting phenotype.
(3)Themodification ofHSP60withHNEmight represent
the necessary self-modification to attain the breaking of
immunological tolerance, and this, in turn, may herald the
transition of the atherosclerotic process fromoxidative stress-
driven to immunity-driven chronic inflammation.
Abbreviations
DC: Dendritic cell
DCFA-DA: 2󸀠-7󸀠-Dichlorofluorescein diacetate
EC: Endothelial cell
FBS: Fetal bovine serum
4-HCCA: Alpha-cyano-4-hydroxycinnamic acid
HNE: 4-Hydroxy-2-nonenal
HSP60: Heat shock 60 kDa protein 1
LDL: Low-density lipoprotein
LOX-1: Lectin-like oxidized LDL receptor-1
LRW: London Resin White
NDM: Nonfat dry milk
oxLDL: Oxidized LDL
PMA: Phorbol 12-myristate 13-acetate
PMSF: Phenylmethanesulfonyl fluoride
PVDF: Polyvinylidene difluoride
ROS: Reactive oxygen species
SMC: Smooth muscle cell
VADC: Vascular-associated dendritic cell.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] U. P. Steinbrecher, “Oxidation of human low density lipoprotein
results in derivatization of lysine residues of apolipoprotein
B by lipid peroxide decomposition products,” The Journal of
Biological Chemistry, vol. 262, no. 8, pp. 3603–3608, 1987.
[2] K. Uchida, “Role of reactive aldehyde in cardiovascular dis-
eases,” Free Radical Biology and Medicine, vol. 28, no. 12, pp.
1685–1696, 2000.
[3] K. Uchida, “4-Hydroxy-2-nonenal: a product and mediator of
oxidative stress,” Progress in Lipid Research, vol. 42, no. 4, pp.
318–343, 2003.
[4] H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry and
biochemistry of 4-hydroxynonenal, malonaldehyde and related
aldehydes,” Free Radical Biology and Medicine, vol. 11, no. 1, pp.
81–128, 1991.
[5] S. Pizzimenti, E. Ciamporcero, M. Daga et al., “Interaction
of aldehydes derived from lipid peroxidation and membrane
proteins,” Frontiers in Physiology, vol. 4, article 242, 2013.
[6] G. Barrera, S. Pizzimenti, E. S. Ciamporcero et al., “Role of 4-
hydroxynonenal-protein adducts in human diseases,” Antioxi-
dants & Redox Signaling, 2015.
[7] A.Mart´ınez, M. Portero-Otin, R. Pamplona, and I. Ferrer, “Pro-
tein targets of oxidative damage in human neurodegenerative
diseases with abnormal protein aggregates,” Brain Pathology,
vol. 20, no. 2, pp. 281–297, 2010.
[8] R. Sultana, M. Perluigi, and D. A. Butterfield, “Lipid peroxida-
tion triggers neurodegeneration: a redox proteomics view into
theAlzheimer disease brain,” Free Radical Biology andMedicine,
vol. 62, pp. 157–169, 2013.
[9] G. Barrera, S. Pizzimenti, R. Muraca et al., “Effect of 4-
hydroxynonenal on cell cycle progression and expression of
differentiation-associated antigens in HL-60 cells,” Free Radical
Biology and Medicine, vol. 20, no. 3, pp. 455–462, 1996.
[10] F. Gentile, S. Pizzimenti, A. Arcaro et al., “Exposure of HL-
60 human leukaemic cells to 4-hydroxynonenal promotes the
formation of adduct(s) with 𝛼-enolase devoid of plasminogen
binding activity,” Biochemical Journal, vol. 422, no. 2, pp. 285–
294, 2009.
[11] M. T. Ross, D. V. Grafham, A. J. Coffey et al., “The DNA
sequence of the human X chromosome,” Nature, vol. 434, no.
7031, pp. 325–337, 2005.
[12] A. Didangelos, X. Yin, K. Mandal et al., “Extracellular matrix
composition and remodeling in human abdominal aortic
aneurysms: a proteomics approach,” Molecular & Cellular Pro-
teomics, vol. 10, no. 8, Article ID M111.008128, 2011.
[13] K. Iwata, C. C. Cafe´-Mendes, A. Schmitt et al., “The human
oligodendrocyte proteome,” Proteomics, vol. 13, no. 23-24, pp.
3548–3553, 2013.
[14] X. Yin, F. Cuello, U. Mayr et al., “Proteomics analysis of the
cardiac myofilament subproteome reveals dynamic alterations
in phosphatase subunit distribution,” Molecular and Cellular
Proteomics, vol. 9, no. 3, pp. 497–509, 2010.
[15] A. L. Fink, “Chaperone-mediated protein folding,” Physiological
Reviews, vol. 79, no. 2, pp. 425–449, 1999.
[16] S. K. Calderwood, M. A. Stevenson, and A. Murshid, “Heat
shock proteins, autoimmunity, and cancer treatment,” Autoim-
mune Diseases, vol. 2012, Article ID 486069, 10 pages, 2012.
[17] C. Habich and V. Burkart, “Heat shock protein 60: regulatory
role on innate immune cells,” Cellular and Molecular Life
Sciences, vol. 64, no. 6, pp. 742–751, 2007.
[18] S. Somersan, M. Larsson, J. F. Fonteneau, S. Basu, P. Srivastava,
and N. Bhardwaj, “Primary tumor tissue lysates are enriched
in heat shock proteins and induce the maturation of human
dendritic cells,” Journal of Immunology, vol. 167, no. 9, pp. 4844–
4852, 2001.
[19] R. S. Vohra, J. E. Murphy, J. H. Walker, S. Ponnambalam, and
S. Homer-Vanniasinkam, “Atherosclerosis and the lectin-like
oxidized low-density lipoprotein scavenger receptor,” Trends in
Cardiovascular Medicine, vol. 16, no. 2, pp. 60–64, 2006.
12 Oxidative Medicine and Cellular Longevity
[20] S. Dunn, R. S. Vohra, J. E. Murphy, S. Homer-Vanniasinkam,
J. H. Walker, and S. Ponnambalam, “The lectin-like oxidized
low-density-lipoprotein receptor: a pro-inflammatory factor in
vascular disease,” Biochemical Journal, vol. 409, no. 2, pp. 349–
355, 2008.
[21] M. Kumano-Kuramochi, Y. Shimozu, C. Wakita et al., “Iden-
tification of 4-hydroxy-2-nonenal-histidine adducts that serve
as ligands for human lectin-like oxidized LDL receptor-1,”
Biochemical Journal, vol. 442, no. 1, pp. 171–180, 2012.
[22] A. J. Lusis, “Atherosclerosis,”Nature, vol. 407, no. 6801, pp. 233–
241, 2000.
[23] D. Li and J. L. Mehta, “Upregulation of endothelial receptor
for oxidized LDL (LOX-1) by oxidized LDL and implications in
apoptosis of human coronary artery endothelial cells. Evidence
form use of antisense LOX-1 mRNA and chemical inhibitors,”
Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no.
4, pp. 1116–1122, 2000.
[24] D. Li and J. L. Mehta, “Antisense to LOX-1 inhibits oxi-
dized LDL-mediated upregulation of monocyte chemoattrac-
tant protein-1 and monocyte adhesion to human coronary
artery endothelial cells,” Circulation, vol. 101, no. 25, pp. 2889–
2895, 2000.
[25] L. Cominacini, A. Fratta Pasini, U. Garbin et al., “Oxidized low
density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in
endothelial cells induces the activation of NF-𝜅B through an
increased production of intracellular reactive oxygen species,”
Journal of Biological Chemistry, vol. 275, no. 17, pp. 12633–12638,
2000.
[26] M. Chen, T. Masaki, and T. Sawamura, “LOX-1, the receptor
for oxidized low-density lipoprotein identified from endothelial
cells: implications in endothelial dysfunction and atheroscle-
rosis,” Pharmacology & Therapeutics, vol. 95, no. 1, pp. 89–100,
2002.
[27] T. Matsunaga, S. Hokari, I. Koyama, T. Harada, and T. Komoda,
“NF-𝜅B activation in endothelial cells treated with oxidized
high-density lipoprotein,” Biochemical and Biophysical Research
Communications, vol. 303, no. 1, pp. 313–319, 2003.
[28] I. V. Smirnova, M. Kajstura, T. Sawamura, andM. S. Goligorsky,
“Asymmetric dimethylarginine upregulates LOX-1 in activated
macrophages: role in foam cell formation,” The American
Journal of Physiology—Heart and Circulatory Physiology, vol.
287, no. 2, pp. H782–H790, 2004.
[29] J. L. Mehta, N. Sanada, C. P. Hu et al., “Deletion of LOX-
1 reduces atherogenesis in LDLR knockout mice fed high
cholesterol diet,” Circulation Research, vol. 100, no. 11, pp. 1634–
1642, 2007.
[30] C. Grundtman, S. B. Kreutmayer, G. Almanzar,M. C.Wick, and
G. Wick, “Heat shock protein 60 and immune inflammatory
responses in atherosclerosis,” Arteriosclerosis, Thrombosis, and
Vascular Biology, vol. 31, no. 5, pp. 960–968, 2011.
[31] T. Nickel, D. Schmauss, H. Hanssen et al., “oxLDL uptake
by dendritic cells induces upregulation of scavenger-receptors,
maturation and differentiation,” Atherosclerosis, vol. 205, no. 2,
pp. 442–450, 2009.
[32] K. Mandal, M. Jahangiri, and Q. Xu, “Autoimmunity to heat
shock proteins in atherosclerosis,” Autoimmunity Reviews, vol.
3, no. 2, pp. 31–37, 2004.
[33] M. Benagiano,M.M.D’Elios, A. Amedei et al., “Human 60-kDa
heat shock protein is a target autoantigen of T cells derived from
atherosclerotic plaques,” Journal of Immunology, vol. 174, no. 10,
pp. 6509–6517, 2005.
[34] M. Knoflach, S. Kiechl, B. Mayrl et al., “T-cell reactivity
againstHSP60 relates to early but not advanced atherosclerosis,”
Atherosclerosis, vol. 195, no. 2, pp. 333–338, 2007.
[35] A. Rossmann, B. Henderson, B. Heidecker et al., “T-cells from
advanced atherosclerotic lesions recognize hHSP60 and have a
restricted T-cell receptor repertoire,” Experimental Gerontology,
vol. 43, no. 3, pp. 229–237, 2008.
[36] Z. Qin, “The use of THP-1 cells as a model for mimicking the
function and regulation of monocytes and macrophages in the
vasculature,” Atherosclerosis, vol. 221, no. 1, pp. 2–11, 2012.
[37] C. Napoli, F. P. Mancini, G. Corso et al., “A simple and
rapid purification procedure minimizes spontaneous oxidative
modifications of low density lipoprotein and lipoprotein (a),”
The Journal of Biochemistry, vol. 121, no. 6, pp. 1096–1101, 1997.
[38] P. J. Moore, K. M. M. Swords, M. A. Lynch, and L. A. Staehelin,
“Spatial organization of the assembly pathways of glycoproteins
and complex polysaccharides in the Golgi apparatus of plants,”
Journal of Cell Biology, vol. 112, no. 4, pp. 589–602, 1991.
[39] R. Balestrini, M. G. Hahn, A. Faccio, K. Mendgen, and P.
Bonfante, “Differential localization of carbohydrate epitopes
in plant cell walls in the presence and absence of arbuscular
mycorrhizal fungi,” Plant Physiology, vol. 111, no. 1, pp. 203–213,
1996.
[40] E. S. Reynolds, “The use of lead citrate at high pH as an
electron-opaque stain in electron microscopy,” The Journal of
Cell Biology, vol. 17, pp. 208–212, 1963.
[41] I. Ohki, T. Ishigaki, T. Oyama et al., “Crystal structure of human
lectin-like, oxidized low-density lipoprotein receptor 1 ligand
binding domain and its ligand recognition mode to OxLDL,”
Structure, vol. 13, no. 6, pp. 905–917, 2005.
[42] L. Foucaud, S. Goulaouic, A. Bennasroune et al., “Oxidative
stress induction by nanoparticles in THP-1 cells with 4-HNE
production: stress biomarker or oxidative stress signalling
molecule?” Toxicology in Vitro, vol. 24, no. 6, pp. 1512–1520,
2010.
[43] S. K. Calderwood, S. S. Mambula, P. J. Gray Jr., and J. R.
Theriault, “Extracellular heat shock proteins in cell signaling,”
FEBS Letters, vol. 581, no. 19, pp. 3689–3694, 2007.
[44] R. M. Vabulas, P. Ahmad-Nejad, C. Da Costa et al., “Endo-
cytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to
activate the toll/interleukin-1 receptor signaling pathway in
innate immune cells,” The Journal of Biological Chemistry, vol.
276, no. 33, pp. 31332–31339, 2001.
[45] A.Motta, C. Schmitz, L. Rodrigues et al., “Mycobacterium tuber-
culosis heat-shock protein 70 impairs maturation of dendritic
cells from bonemarrow precursors, induces interleukin-10 pro-
duction and inhibits T-cell proliferation in vitro,” Immunology,
vol. 121, no. 4, pp. 462–472, 2007.
[46] P. Stocki, X. N. Wang, and A. M. Dickinson, “Inducible heat
shock protein 70 reduces T cell responses and stimulatory
capacity of monocyte-derived dendritic cells,” Journal of Biolog-
ical Chemistry, vol. 287, no. 15, pp. 12387–12394, 2012.
[47] A. Tesnie´re, L. Apetoh, F. Ghiringhelli et al., “Immunogenic
cancer cell death: a key-lock paradigm,” Current Opinion in
Immunology, vol. 20, no. 5, pp. 504–511, 2008.
[48] F. Chalmin, S. Ladoire, G. Mignot et al., “Membrane-
associated Hsp72 from tumor-derived exosomes mediates
STAT3-dependent immunosuppressive function of mouse and
human myeloid-derived suppressor cells,” The Journal of Clini-
cal Investigation, vol. 120, no. 2, pp. 457–471, 2010.
Oxidative Medicine and Cellular Longevity 13
[49] Q. Xu, G. Schett, H. Perschinka et al., “Serum soluble heat
shock protein 60 is elevated in subjects with atherosclerosis in a
general population,” Circulation, vol. 102, no. 1, pp. 14–20, 2000.
[50] Q. Xiao, K. Mandal, G. Schett et al., “Association of serum-
soluble heat shock protein 60 with carotid atherosclerosis:
clinical significance determined in a follow-up study,” Stroke,
vol. 36, no. 12, pp. 2571–2576, 2005.
[51] X. Zhang, M. He, L. Cheng et al., “Elevated heat shock protein
60 levels are associated with higher risk of coronary heart
disease in Chinese,” Circulation, vol. 118, no. 25, pp. 2687–2693,
2008.
[52] D. Giannessi, C. Colotti, M. Maltinti et al., “Circulating heat
shock proteins and inflammatory markers in patients with
idiopathic left ventricular dysfunction: their relationships with
myocardial and microvascular impairment,” Cell Stress and
Chaperones, vol. 12, no. 3, pp. 265–274, 2007.
[53] Q. Xu, R. Kleindienst, W. Waitz, H. Dietrich, and G. Wick,
“Increased expression of heat shock protein 65 coincides with
a population of infiltrating T lymphocytes in atherosclerotic
lesions of rabbits specifically responding to heat shock protein
65,”The Journal of Clinical Investigation, vol. 91, no. 6, pp. 2693–
2702, 1993.
[54] G. Millonig, G. T. Malcom, and G. Wick, “Early inflammatory-
immunological lesions in juvenile atherosclerosis from the
Pathobiological Determinants of Atherosclerosis in Youth
(PDAY)-study,” Atherosclerosis, vol. 160, no. 2, pp. 441–448,
2002.
[55] M. Knoflach, S. Kiechl, D. Penz et al., “Cardiovascular risk
factors and atherosclerosis in young women: atherosclerosis
risk factors in female youngsters (ARFY study),” Stroke, vol. 40,
no. 4, pp. 1063–1069, 2009.
[56] M. Knoflach, S. Kiechl, M. Kind et al., “Cardiovascular risk
factors and atherosclerosis in young males: ARMY study
(atherosclerosis risk-factors in male youngsters),” Circulation,
vol. 108, no. 9, pp. 1064–1069, 2003.
[57] Q. Xu, G. Oberhuber, M. Gruschwitz, and G. Wick, “Im-
munology of atherosclerosis: cellular composition and major
histocompatibility complex class II antigen expression in
aortic intima, fatty streaks, and atherosclerotic plaques in
young and aged human specimens,” Clinical Immunology and
Immunopathology, vol. 56, no. 3, pp. 344–359, 1990.
[58] R. Kleindienst, Q. Xu, J. Willeit, F. R. Waldenberger, S.
Weimann, and G. Wick, “Immunology of atherosclerosis:
demonstration of heat shock protein 60 expression and T lym-
phocytes bearing 𝛼/𝛽 or 𝛾/𝛿 receptor in human atherosclerotic
lesions,” The American Journal of Pathology, vol. 142, no. 6, pp.
1927–1937, 1993.
[59] G. Millonig, H. Niederegger, W. Rabl et al., “Network of
vascular-associated dendritic cells in intima of healthy young
individuals,” Arteriosclerosis, Thrombosis, and Vascular Biology,
vol. 21, no. 4, pp. 503–508, 2001.
[60] G. Wick, R. Kleindienst, H. Dietrich, and Q. Xu, “Is atheroscle-
rosis an autoimmune disease?” Trends in Food Science and
Technology, vol. 3, pp. 114–119, 1992.
[61] C. Grundtman and G. Wick, “The autoimmune concept of
atherosclerosis,” Current Opinion in Lipidology, vol. 22, no. 5,
pp. 327–334, 2011.
[62] D. Li, H. Chen, F. Romeo, T. Sawamura, T. Saldeen, and J.
L. Mehta, “Statins modulate oxidized low-density lipoprotein-
mediated adhesion molecule expression in human coronary
artery endothelial cells: Role of LOX-1,” Journal of Pharmacology
and Experimental Therapeutics, vol. 302, no. 2, pp. 601–605,
2002.
[63] L. Cominacini, A. Rigoni, A. F. Pasini et al., “The binding of
oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-
1 reduces the intracellular concentration of nitric oxide in
endothelial cells through an increased production of superox-
ide,” Journal of Biological Chemistry, vol. 276, no. 17, pp. 13750–
13755, 2001.
[64] D. Steinberg, “Role of oxidized LDL and antioxidants in
atherosclerosis,” Advances in Experimental Medicine and Biol-
ogy, vol. 369, pp. 39–48, 1995.
[65] J. Frostega˚rd, B. Kjellman, M. Gidlund, B. Andersson, S. Jindal,
and R. Kiessling, “Induction of heat shock protein inmonocytic
cells by oxidized low density lipoprotein,” Atherosclerosis, vol.
121, no. 1, pp. 93–103, 1996.
[66] W. van Eden, R. van Der Zee, A. G. A. Paul et al., “Do
heat shock proteins control the balance of T-cell regulation in
inflammatory diseases?” Immunology Today, vol. 19, no. 7, pp.
303–307, 1998.
[67] J. Derbinski, J. Ga¨bler, B. Brors et al., “Promiscuous gene
expression in thymic epithelial cells is regulated at multiple
levels,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 33–
45, 2005.
[68] J. Derbinski and B. Kyewski, “How thymic antigen present-
ing cells sample the body’s self-antigens,” Current Opinion in
Immunology, vol. 22, no. 5, pp. 592–600, 2010.
[69] C. E. Teh, S. R. Daley, A. Enders, and C. C. Goodnow,
“T-cell regulation by casitas B-lineage lymphoma (Cblb) is a
critical failsafe against autoimmune disease due to autoimmune
regulator (Aire) deficiency,”Proceedings of theNational Academy
of Sciences of the United States of America, vol. 107, no. 33, pp.
14709–14714, 2010.
[70] A. Liu, J. Y. Ming, R. Fiskesund et al., “Induction of dendritic
cell-mediated T-cell activation by modified but not native low-
density lipoprotein in humans and inhibition by annexin 5.
Involvement of heat shock proteins,” Arteriosclerosis, Thrombo-
sis, and Vascular Biology, vol. 35, no. 1, pp. 197–205, 2014.
